FDA ALERTS AND PUBLIC HEALTH ADVISORIES
Suicidality in Adults Being Treated with
Antidepressant Medications
Suicidality in Children and Adolescents Being
Treated With Antidepressant Medications
Treatment Challenges of Depression in Pregnancy
Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans),
Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective
Serotonin / Norepinephrine Reuptake Inhibitors (SNRIs)
May Result in Life-threatening Serotonin Syndrome
FDA Advising of Risk of Birth Defects with Paxil
Agency Requiring Updated Product Labeling
FDA Reviews Data for Antidepressant Use in Adults
|